Papers
8
Total Citations
268
H-Index
6
About
Christina Fotopoulou is a prominent gynecologic oncologist whose research has made significant contributions to the understanding and treatment of borderline ovarian tumors (BOT) and early-stage cervical cancer. Through her leadership in landmark multicenter studies, particularly the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study, she has helped reshape clinical approaches to BOT management, examining how age, surgical staging, and serum CA125 levels influence prognosis and patient outcomes across hundreds of cases. Her most-cited work (75 citations) revealed critical age-dependent differences in BOT characteristics, while her surgical staging analyses demonstrated that incomplete staging negatively affects prognosis in serous BOT patients. Fotopoulou has also been instrumental in advancing fertility-sparing and minimally invasive surgical techniques in cervical cancer, co-leading the International Radical Trachelectomy Assessment (IRTA) study, which garnered over 53 citations and informed global surgical standards. Her ongoing work through the ENGOT-cx23/LASH trial continues to evaluate the oncologic safety of minimally invasive approaches in low-risk cervical cancer. Fotopoulou's consistent contributions to quality-of-life research further underscore her holistic, patient-centered approach to gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3International radical trachelectomy assessment: IRTA study53 citations · 2019
- 4
- 5The Value of Serum CA125 in the Diagnosis of Borderline Tumors of the Ovary14 citations · 2015
- 6
- 7
- 8